NumFin

YanAn Bicon Pharmaceutical Listed Company

Sümbol: 002411.SZ

SHZ

0.62

CNY

Turuhind täna

  • -0.5881

    P/E suhe

  • -0.0152

    PEG suhe

  • 950.01M

    MRK Cap

  • 0.00%

    DIV tootlus

YanAn Bicon Pharmaceutical Listed Company (002411-SZ) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete YanAn Bicon Pharmaceutical Listed Company (002411.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 3453.038 M, mis on 0.251 % gowth. Kogu perioodi keskmine brutokasum on 957.744 M, mis on 0.494 %. Keskmine brutokasumi suhtarv on 0.250 %. Ettevõtte eelmise aasta tulemuse puhaskasv on 0.599 %, mis on võrdne 0.957 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes YanAn Bicon Pharmaceutical Listed Company fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus -0.206. Käibevara valdkonnas on 002411.SZ aruandlusvaluutas 6074.924. Märkimisväärne osa neist varadest, täpsemalt 950.226, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 0.128%. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 231.948 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on -0.636%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 5773.341 aruandlusvaluutas. Selle aspekti aastane muutus on -0.243%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 4260.171, varude hind on 788.22 ja firmaväärtus 1614.72, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 531.04. Kontovõlad ja lühiajalised võlad on vastavalt 1892.02 ja 1552.99. Koguvõlg on 1784.94, netovõlg on 907.84. Muud lühiajalised kohustused moodustavad 4597.03, mis lisandub kohustuste kogusummale 8698.72. Lõpuks hinnatakse viidatud aktsia 0, kui see on olemas.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006

balance-sheet.row.cash-and-short-term-investments

3267.61950.2842.6710.4
963.2
1354.6
2058.6
5095.2
1105.6
22.7
109.6
231.9
326.6
321.8
8.6
16.9
24.1
6.8

balance-sheet.row.short-term-investments

194.7473.1-240.1-216.7
-251.7
-299.5
0
0
0
0
0
0
0
0
0
0
0
0.6

balance-sheet.row.net-receivables

19813.774260.25748.35945.8
5875
3588
2562.5
1441.4
1315.9
581.7
327.5
427.3
358.2
293.4
136.8
80
53.8
76.7

balance-sheet.row.inventory

3740.51788.2978.6763.9
764.2
684.3
569.3
258.4
278.3
115.8
119.5
83.1
76.5
50.3
66.4
66.6
42.9
24.3

balance-sheet.row.other-current-assets

319.476.3106.985.1
86.2
393.1
1760.8
2336.1
5.2
3.8
-3.6
-3.9
-7.6
-1.9
-2.6
-2.6
-2.3
-2.6

balance-sheet.row.total-current-assets

27141.296074.97676.57505.3
7688.6
6020
6951.2
9131
2704.9
724.1
552.9
738.3
753.6
663.6
209.2
160.9
118.4
105.3

balance-sheet.row.property-plant-equipment-net

18876.1329106651.18593.4
9820.8
10052.8
8195.1
5914.7
3567.8
747
678.8
410.3
262.2
196.6
160.1
135.6
88.5
55.9

balance-sheet.row.goodwill

6512.071614.71641.31641.3
1694.4
1694.4
2016.8
1937.4
1938.7
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

2412.53531670.9774.6
835
874.9
784.5
324.5
258.3
70.3
72.1
46.7
41.8
40.4
27.3
28.1
20.2
14.6

balance-sheet.row.goodwill-and-intangible-assets

8924.592145.82312.22416
2529.5
2569.4
2801.3
2261.9
2197
70.3
72.1
46.7
41.8
40.4
27.3
28.1
20.2
14.6

balance-sheet.row.long-term-investments

-30.09-15288.5261.6
296.8
341.7
335
42.8
34.5
4.8
0
0
0
0
0
0
0
0.9

balance-sheet.row.tax-assets

2272.59984.9151.9171.9
103.2
73.4
36.9
23.4
22.9
6.5
4.9
3.8
2.4
1
0.7
1.8
0.7
0.7

balance-sheet.row.other-non-current-assets

9353.572761.11643.1259.3
1535.7
1553.9
1924.6
730.7
338.8
13.8
0.2
0.1
0.3
0.6
0
0
0
1.3

balance-sheet.row.total-non-current-assets

39396.788786.711046.811702.2
14286
14591.2
12957.9
8930.6
6126.6
837.5
756.1
460.8
306.7
238.5
188.1
165.5
109.4
72.7

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

66538.0814861.618723.319207.4
21974.6
20611.2
19909.1
18061.6
8831.5
1561.6
1309
1199.2
1060.3
902.2
397.4
326.4
227.9
178

balance-sheet.row.account-payables

7878.3618922036.32142.7
3024.9
2150.2
1327.9
585.7
658.8
154.9
98.9
60.1
72.8
40.4
46.9
64.4
21.5
11.3

balance-sheet.row.short-term-debt

10572.8715534617.74005.3
4277
4945.2
399
213.4
835.5
460
326.6
262.8
100
68.7
145.6
102.5
63
17.2

balance-sheet.row.tax-payables

3673.991062.41031.9779
584.2
312.7
212.8
249.6
202.4
10.3
-22.7
-10.2
-0.7
6.5
3.4
3.8
20.1
10.7

balance-sheet.row.long-term-debt-total

2554.55231.9283.21084.8
1751.7
1123.8
7051.6
6893.5
1284.6
0
0
0
30
0
0
0
0
14

Deferred Revenue Non Current

504.79126.1132.9139.2
200.3
207.7
145.4
128.3
56
27.1
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

58---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

14694.58459720.246.3
77.5
2191.9
1639.1
1686.7
605.9
30.1
-2
6.8
44.1
40.9
33.1
33.6
65.2
103.9

balance-sheet.row.total-non-current-liabilities

4284.47656.7727.61285.9
2087.7
1427.2
7232.7
7112.8
1498.5
27.1
16.1
11.9
38
1.6
2.1
2.4
0.4
14

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

55.8512.629.919.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

37430.288698.710650.410276.4
11713.7
11027.3
10598.7
9598.6
3598.7
672.1
439.5
341.6
254.8
151.6
227.8
202.9
150.1
146.4

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

7113.221778.31778.31778.3
1778.3
1778.3
1778.3
1778.3
1500.1
348.3
348.3
232.2
232.2
129
64.2
64.2
64.2
10

balance-sheet.row.retained-earnings

-1660.9-1317.7247.41204.5
2586.5
2256.8
2005.8
1247
445.3
236.4
217.9
205.9
162.1
115.8
79.5
42.6
6.7
11.2

balance-sheet.row.accumulated-other-comprehensive-income-loss

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

21853.185312.85601.35522.6
5467.4
5296.6
5296.6
5285.4
3233.5
275.6
275.6
387.8
379.2
476.4
6.8
3.4
0.2
4.7

balance-sheet.row.total-stockholders-equity

27305.55773.376278505.5
9832.1
9331.7
9080.7
8310.7
5179
860.2
841.8
825.8
773.5
721.3
150.5
110.3
71.1
25.9

balance-sheet.row.total-liabilities-and-stockholders-equity

66538.0814861.618723.319207.4
21974.6
20611.2
19909.1
18061.6
8831.5
1561.6
1309
1199.2
1060.3
902.2
397.4
326.4
227.9
178

balance-sheet.row.minority-interest

1802.3389.5446425.6
428.7
252.3
229.6
152.3
53.9
29.3
27.6
31.7
32
29.3
19.1
13.2
6.7
5.7

balance-sheet.row.total-equity

29107.86162.980738931
10260.8
9584
9310.4
8463.1
5232.8
889.5
869.4
857.5
805.5
750.6
169.6
123.5
77.8
31.6

balance-sheet.row.total-liabilities-and-total-equity

66538.08---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

213.1358.148.444.9
45.1
42.3
42.9
41.5
33.6
4.7
0
0
0
0
0
0
0
1.5

balance-sheet.row.total-debt

13127.421784.94900.95090.1
6028.7
6069
7450.6
7107
2120.1
460
326.6
262.8
130
68.7
145.6
102.5
63
31.2

balance-sheet.row.net-debt

10006.06907.84058.24379.7
5065.5
4714.4
5392
2011.8
1014.5
437.3
217
31
-196.6
-253.1
137
85.6
38.9
24.9

Rahavoogude aruanne

YanAn Bicon Pharmaceutical Listed Company finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 3.597 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab 0.000 erinevust võrreldes eelmise aastaga. Huvitav on see, et osa ettevõtte aktsiatest, täpsemalt 0, ostis ettevõte ise tagasi. Selle tegevuse tulemusena muutus 0.000 võrreldes eelmise aastaga. Vahepeal on ettevõtte võlgnevused praegu 0 aruandlusvaluutas. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli 842831286.000. See on 12.830 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 350.08, -10.27, -3338.95, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -2021.41 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui 2222.46, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006

cash-flows.row.net-income

-1560.63-1054.7-659.7-1054.3
378.6
425.9
900.9
962.1
568.3
30
24.1
62.8
72.1
51
46.7
45.7
35.6
0

cash-flows.row.depreciation-and-amortization

0350.1403.3338.9
266.1
201.1
180.9
135.3
43.2
37.3
31.2
24
21
16
13.4
10
6.3
0

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

02112.3-732.8-1104.2
-1245.2
-1012.4
-990.4
261.9
19.8
-183.7
34.7
-79.1
-72.5
-146.6
-76.9
-35.1
18.7
0

cash-flows.row.account-receivables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-8.4-212.8-1.6
-80.8
-121.8
-61.8
19.1
15.3
3.7
-36.4
-6.7
-26.1
16.1
0.2
-32.8
-18.6
0

cash-flows.row.account-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

02120.8-520-1102.6
-1164.4
-890.6
-928.7
242.8
4.4
-187.4
71.1
-72.5
-46.3
-162.7
-77.1
-2.3
37.2
0

cash-flows.row.other-non-cash-items

01517.51590.61454.5
765.1
788.6
-55.8
153.6
54.2
22
12
7.9
14.3
16.8
10
16.6
0.3
0

cash-flows.row.net-cash-provided-by-operating-activities

-1560.63000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-1498.5-1452.8-281.1-143.7
-343.2
-1711.9
-3396.7
-2123.3
-1691.3
-92.6
-226.3
-233
-76.3
-62.4
-36
-63.6
-43.9
-24.7

cash-flows.row.acquisitions-net

1335.581335.600.1
-4.9
0
-24.6
19
0.2
-1.8
-22.9
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

-25.7-25.6205.5-0.3
-5.9
-42.6
2.4
-11.2
-3.2
-5
0
0
0
0
0
0
0
-0.7

cash-flows.row.sales-maturities-of-investments

0.019963.80.7
13.7
35.1
105.2
33.4
1.2
32.3
0
0
0
0
0
0
0.7
0

cash-flows.row.other-investing-activites

985.62-10.3132.81194.8
-675.3
1210.7
53.5
-2434.1
-87.8
-28.7
9.1
15.9
0
0
0
0.2
0.5
0

cash-flows.row.net-cash-used-for-investing-activites

797.01842.860.91051.7
-1015.5
-508.8
-3262.7
-4535.1
-1781.1
-95.8
-240.1
-217.2
-76.2
-62.4
-36
-63.4
-42.7
-25.4

cash-flows.row.debt-repayment

-3769.74-3339-647.6-3023.1
-5908.1
-6838
-217.5
-1402
-103
-534.6
-474.8
-160
-148.7
-241.7
-166.5
-91.3
-65.5
-13.8

cash-flows.row.common-stock-issued

0000
0
0
0
2385.2
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
4084.5
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-2054.05-2021.4-200.1-431.2
-505.8
-707.6
-511.9
-179.1
-733.5
-29.5
-28.2
-22.1
-13
-5.8
-8.1
-20.2
-19.5
-4.8

cash-flows.row.other-financing-activites

2695.352222.5460.12738.8
6504.9
6899.2
659.5
6394
2452.6
667.1
519.3
288.9
207.9
685.8
208.9
130.8
84
42.3

cash-flows.row.net-cash-used-provided-by-financing-activities

-3128.44-3137.9-387.6-715.5
90.9
-646.4
-69.9
7198.1
1616.1
102.9
16.3
106.8
46.2
438.3
34.3
19.3
-1
23.7

cash-flows.row.effect-of-forex-changes-on-cash

23.7523.7-1-0.4
-0.9
0.5
-0.2
2.9
0.1
0.3
-0.5
0.1
-0.1
0
0
-0.3
-0.3
-0.1

cash-flows.row.net-change-in-cash

-227.08653.9273.8-29.3
-760.9
-751.4
-3297.1
4178.7
520.6
-87
-122.3
-94.8
4.8
313.2
-8.4
-7.2
16.8
-5.6

cash-flows.row.cash-at-end-of-period

2538.321154.2500.7226.8
255.3
1016.2
1767.7
5064.7
886
21.3
108.2
230.6
325.3
320.6
7.4
15.8
23
6.2

cash-flows.row.cash-at-beginning-of-period

2765.4500.3226.8256.1
1016.2
1767.7
5064.8
886.1
365.4
108.2
230.6
325.3
320.6
7.4
15.8
23
6.2
11.8

cash-flows.row.operating-cash-flow

-1560.632925.3601.4-365
164.6
403.2
35.6
1512.8
685.4
-94.3
102
15.5
34.9
-62.7
-6.8
37.2
60.9
0

cash-flows.row.capital-expenditure

-1498.5-1452.8-281.1-143.7
-343.2
-1711.9
-3396.7
-2123.3
-1691.3
-92.6
-226.3
-233
-76.3
-62.4
-36
-63.6
-43.9
-24.7

cash-flows.row.free-cash-flow

-3059.131472.4320.3-508.8
-178.6
-1308.7
-3361.1
-610.5
-1005.9
-187
-124.3
-217.5
-41.4
-125.1
-42.8
-26.4
17
-24.7

Kasumiaruande rida

YanAn Bicon Pharmaceutical Listed Company tulud muutusid võrreldes eelmise perioodiga 0.058%. 002411.SZ brutokasum on teatatud 2031.19. Ettevõtte tegevuskulud on 1719.49, mille muutus võrreldes eelmise aastaga on 100.691%. Kulud amortisatsioonikulud on 350.08, mis on -0.132% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 1719.49, mis näitab 100.691% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab -0.719% kasvu võrreldes eelmise aastaga. Tegevustulu on 342.95, mis näitab -0.719% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on 0.599%. Eelmise aasta puhaskasum oli -1054.7.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006

income-statement-row.row.total-revenue

7057.748106.37663.26939.5
9328.2
8446.8
5368
3723.9
2023.4
1060.3
894.7
1009.8
1049
914.2
678.2
731.9
445.1
319.2

income-statement-row.row.cost-of-revenue

5817.126075.15311.95613.1
7271.1
6301.8
3499.5
1683.5
780.1
873.8
732.5
828.1
866.3
767.4
569.5
602.5
371.9
271.9

income-statement-row.row.gross-profit

1240.612031.22351.21326.4
2057.1
2145
1868.5
2040.4
1243.3
186.5
162.2
181.7
182.8
146.7
108.7
129.4
73.3
47.3

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

127.63---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

34.99---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

290.11---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

1153.161157.5325.1306.9
265.2
-0.4
-12.3
43.1
-1.9
10
23.3
15
12.7
4.6
11.1
2.2
2.1
0.5

income-statement-row.row.operating-expenses

1605.891719.5856.8946.7
934.6
895.8
792
828.9
499.3
136.1
138
116.1
108.1
84.6
53.1
53.9
31
26.6

income-statement-row.row.cost-and-expenses

7423.027794.66168.76559.8
8205.6
7197.7
4291.6
2512.4
1279.4
1009.9
870.4
944.2
974.3
852
622.5
656.4
402.9
298.5

income-statement-row.row.interest-income

-4.19-61620.7
37.7
20.9
55.6
35.1
4.4
0.9
0
7.5
7.3
3.6
0.2
0.3
0
0

income-statement-row.row.interest-expense

201.51283.7357.91135.6
560.9
255.1
90.5
176.3
18
22.8
13.7
10.5
4.4
7.8
9.2
11.4
4.6
1.6

income-statement-row.row.selling-and-marketing-expenses

290.11---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-518.6-2001.5-1587.9-2048.9
-781.2
-639.6
-12.3
15.6
-2.6
9.9
23
14.1
12.7
4.6
11.1
2.2
2.1
0.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

1153.161157.5325.1306.9
265.2
-0.4
-12.3
43.1
-1.9
10
23.3
15
12.7
4.6
11.1
2.2
2.1
0.5

income-statement-row.row.total-operating-expenses

-518.6-2001.5-1587.9-2048.9
-781.2
-639.6
-12.3
15.6
-2.6
9.9
23
14.1
12.7
4.6
11.1
2.2
2.1
0.5

income-statement-row.row.interest-expense

201.51283.7357.91135.6
560.9
255.1
90.5
176.3
18
22.8
13.7
10.5
4.4
7.8
9.2
11.4
4.6
1.6

income-statement-row.row.depreciation-and-amortization

1448.87350.1403.3338.9
266.1
201.1
180.9
135.3
43.2
37.3
31.2
24
21
16
13.4
10
6.3
3

income-statement-row.row.ebitda-caps

-271.28---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-1720.15342.91219.9930.6
1257.8
609.9
1083.9
1118.6
689.9
24.9
6.7
59.7
72.7
55
44.8
54.6
40.2
18.1

income-statement-row.row.income-before-tax

-2238.75-1658.6-368-1118.3
476.6
609.5
1071.6
1134.3
687.3
34.8
29.7
73.8
85.4
59.6
55.9
56.8
42.3
18.6

income-statement-row.row.income-tax-expense

-692.52-603.9291.7-45.5
98
183.6
170.7
172.2
119
4.7
5.6
11
13.2
8.5
9.2
11.1
6.8
4

income-statement-row.row.net-income

-1560.63-1054.7-659.7-1072.8
354.7
404.2
892.6
953.6
568.3
28.4
26.9
61.6
62.6
39.2
40.3
39.1
33.2
14.4
Sarnased aktsiad
Sind võib huvitada ka:
004000.KS
LOTTE Fine Chemical Co., Ltd..
45150 KRW
KSC
GULPOLY.BO
Gulshan Polyols Limited.
213 INR
BSE
ZAP.WA
Zaklady Azotowe Pulawy S.A..
60 PLN
WSE
005420.KS
Cosmo Chemical Co., Ltd..
38950 KRW
KSC
PUNJABCHEM.NS
Punjab Chemicals and Crop Protection Limited.
1198.75 INR
NSE
PUNJABCHEM.BO
Punjab Chemicals and Crop Protection Limited.
982.5 INR
BSE
002971.SZ
Hubei Heyuan Gas Co.,Ltd..
25.84 CNY
SHZ
DIAMINESQ.BO
Diamines and Chemicals Limited.
564.05 INR
BSE
605399.SS
Jiang Xi Chenguang New Materials Co.,Ltd..
12.43 CNY
SHH
UNIP6.SA
Unipar Carbocloro S.A..
56.35 BRL
SAO
CHCC
China Chemical Corp..
0.0002 USD
PNK

Korduma kippuv küsimus

Mis on YanAn Bicon Pharmaceutical Listed Company (002411.SZ) koguvara?

YanAn Bicon Pharmaceutical Listed Company (002411.SZ) koguvara on 14861598713.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on 3146759640.000.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.155.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -1.981.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -0.303.

Mis on ettevõtte kogutulu?

Kogutulu on -0.342.

Mis on YanAn Bicon Pharmaceutical Listed Company (002411.SZ) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -1054699022.740.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 1784935683.000.

Mis on tegevuskulude arv?

Tegevuskulud on 1719493052.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 489995625.000.